A way to provide medical care to a patient who is not eligible for treatment by participating in a clinical trial, but who has a serious or life-threatening illness for which other treatments are not available. This extended approach allows the patient to receive promising anti-cancer treatments that have not yet been approved, when no other treatment is possible.
Compassionate use, Early Access program, Named patient program